Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary B. Daly, MD, PhD
Fox Chase Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Jonsson Comprehensive Cancer Center at Ucla
Los Angeles, California, United States
- Colorado Gynecologic Oncology Group P.C.
Aurora, Colorado, United States
- Helen and Harry Gray Cancer Center at Hartford Hospital
Hartford, Connecticut, United States
- George Bray Cancer Center at New Britain General Hospital
New Britain, Connecticut, United States
- Michael & Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital
Fort Lauderdale, Florida, United States
- Evanston Northwestern Healthcare - Evanston Hospital
Evanston, Illinois, United States
- St. Vincent Indianapolis Hospital
Indianapolis, Indiana, United States
- Memorial Hospital of South Bend
South Bend, Indiana, United States
- Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, United States
- Markey Cancer Center at University of Kentucky Chandler Medical Center
Lexington, Kentucky, United States
- William Beaumont Hospital - Royal Oak Campus
Royal Oak, Michigan, United States
- University of Minnesota Medical Center & Children'S Hospital - Fairview
Minneapolis, Minnesota, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- Ccop - Cancer Research for the Ozarks
Springfield, Missouri, United States
- Hulston Cancer Center at Cox Medical Center South
Springfield, Missouri, United States
- St. John'S Regional Health Center
Springfield, Missouri, United States
- Siteman Cancer Center at Barnes-Jewish Hospital
St Louis, Missouri, United States
- Ccop - Northern New Jersey
Hackensack, New Jersey, United States
- Cancer Institute of New Jersey at Cooper - Voorhees
Voorhees Township, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Mount Sinai Medical Center
New York, New York, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
- Blumenthal Cancer Center at Carolinas Medical Center
Charlotte, North Carolina, United States
- Mcdowell Cancer Center at Akron General Medical Center
Akron, Ohio, United States
- Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio, United States
- Mount Carmel Health - West Hospital
Columbus, Ohio, United States
- Riverside Methodist Hospital Cancer Care
Columbus, Ohio, United States
- Hillcrest Cancer Center at Hillcrest Hospital
Mayfield Heights, Ohio, United States
- Oklahoma University Medical Center
Oklahoma City, Oklahoma, United States
- Oregon Health & Science University Cancer Institute
Portland, Oregon, United States
- Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
Allentown, Pennsylvania, United States
- University of Texas Medical Branch
Galveston, Texas, United States
- Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont, United States
- Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2002
- Primary completion
- 31 Dec 2006
- Completion
- —
- Last update posted
- 10 Jun 2013
- Registered enrollment
- 71
- Registry id
- NCT00017134
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.